ÂÜÀòÂÒÂ×

Pallavur Sivakumar is an accomplished professional in the field of immunology and drug discovery, currently serving as Vice President of the CSO Partner Team at Curie.Bio since September 2024. Sivakumar's extensive experience includes notable roles such as Vice President and Head of Discovery for Immuno-Oncology and Cell Therapy at Bristol-Myers Squibb from November 2019 to May 2024, and multiple positions at Celgene, including Vice President and Executive Director of Immuno-Oncology Translational Development. Additionally, Sivakumar has held several board observer and directorial positions with organizations such as EvolveImmune Therapeutics, Outpace Bio, and EMERALD CITY FOOTBALL CLUB. Academic credentials include a Ph.D. in Immunology from UT Southwestern Medical Center and a BPharm, MSc in Pharmacy and Biological Sciences from Birla Institute of Technology and Science, Pilani.